New York Cancer and Blood Specialists

New York, NY

Sorting 3 by

Accepting patients

SUCCESSOR-1

Phase 3 Clinical Trial Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Bortezomib and Dexamethasone Compared to Pomalidomide, Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma
Learn more
  • CELMoD
  • Randomization
  • Phase 3

Accepting patients

KPG-818

Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects
Learn more
  • CELMoD
  • Phase 1

Accepting patients

CERVINO

A Phase 3, Multicenter, Randomized, Open Label Study of ABBV-383 Compared With Standard Available Therapies in Subjects With Relapsed or Refractory Multiple Myeloma (3L+ RRMM Monotherapy Study)
Learn more
  • Bispecific Antibody
  • BCMA
  • CD3
  • Randomization
  • Phase 3